Tin tức & Cập nhật

Chỉ hiển thị Multimedia
GLP-1 RAs reduce depression, substance use in young patients with obesity, MASLD
GLP-1 RAs reduce depression, substance use in young patients with obesity, MASLD
17 Jun 2025 bởiStephen Padilla

In paediatric patients with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), treatment with GLP-1 receptor agonists (RAs) results in a decrease in depression and substance use, as shown in a study presented at ESPGHAN 2025.

GLP-1 RAs reduce depression, substance use in young patients with obesity, MASLD
17 Jun 2025
DASH diet during pregnancy helps prevent LGA newborns
DASH diet during pregnancy helps prevent LGA newborns
11 Jun 2025
Fatigue prevalent in paediatric IBD patients
Fatigue prevalent in paediatric IBD patients
09 Jun 2025